We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

91 hedge funds and large institutions have $23.5M invested in Zomedica Corp. in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

21% more capital invested

Capital invested by funds: $19.5M → $23.5M (+$4M)

5% more funds holding

Funds holding: 87 → 91 (+4)

Holders
91
Holders Change
+4
Holders Change %
+4.6%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
17
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$510K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.9K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$36K
4
Morgan Stanley
Morgan Stanley
New York
+$31.6K
5
MCC
Money Concepts Capital
Florida
+$31.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$182K
2
VF
Virtu Financial
New York
-$115K
3
Charles Schwab
Charles Schwab
California
-$73K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$46K
5
UBS Group
UBS Group
Switzerland
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWA
1
Arete Wealth Advisors
Illinois
$8.25M +$1.07K +5,204 +11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.96M +$510K +2,491,265 +5%
BlackRock
3
BlackRock
New York
$1.84M -$4.32K -21,090 -0.2%
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$1.82M – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.45M -$4.37K -21,318 -0.2%
State Street
6
State Street
Massachusetts
$544K – – –
BBHC
7
Brown Brothers Harriman & Co
New York
$373K – – –
Northern Trust
8
Northern Trust
Illinois
$274K – – –
PWMG
9
Pinnacle Wealth Management Group
Michigan
$158K -$41K -200,000 -17%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$94.6K -$231 -1,127 -0.2%
Morgan Stanley
11
Morgan Stanley
New York
$71K +$31.6K +154,222 +55%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$54K +$29.5K +144,000 +77%
Jane Street
13
Jane Street
New York
$44K +$21.3K +104,143 +63%
GT
14
Glenmede Trust
Pennsylvania
$39.6K – – –
SCA
15
Snowden Capital Advisors
New York
$38.8K +$9.63K +47,000 +25%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$37.4K +$46.9K +228,799 +28,247%
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$35K -$2.11K -10,300 -5%
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$30.5K +$36K +175,521 +1,493%
MCC
19
Money Concepts Capital
Florida
$24.8K +$31.2K +152,341 New
TSS
20
Two Sigma Securities
New York
$21K +$1.11K +5,397 +4%
Renaissance Technologies
21
Renaissance Technologies
New York
$21K -$182K -889,500 -88%
I
22
INVST
Indiana
$18.5K – – –
Victory Capital Management
23
Victory Capital Management
Texas
$17.8K -$10 -51 -0%
EDRH
24
Edmond de Rothschild Holding
Switzerland
$16.3K – – –
Cerity Partners
25
Cerity Partners
New York
$16.3K +$16.4K +80,000 +400%
1
2 3 4

ZOM Hedge Fund Activity: Q4 2022 in Review

91 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2022, worth a combined $23.5M — up 21% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZOM positions and 8 closed out — a net gain of 5 holders — while 17 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $510K. The largest seller was Renaissance Technologies, cutting an estimated $182K.

  • 91 institutional investors held Zomedica Corp. (ZOM) as of Q4 2022, up from 87 in Q3 2022.
  • Funds reported $23.5M of Zomedica Corp. stock for Q4 2022, up 21% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q4 2022 and 8 closed out, a net change of +5 holders.
  • The largest Zomedica Corp. buyer in Q4 2022 was Vanguard Group, an estimated $510K added.
  • The largest Zomedica Corp. seller in Q4 2022 was Renaissance Technologies, an estimated $182K sold.

Based on aggregated 13F filings for Q4 2022.